Clinical Trial Transparency: Law requires disclosure of Failures

http://www.scientificamerican.com/article/us-toughens-rules-for-clinical-trial-transparency/

Science advances from learning about flaws, mistakes and failures. Why this wasn't implemented before is a bit shocking.
On the surface, this new policy sounds great. The critic in me wonders how unsuccessful trials will be 'candy coated' to limit impact on clinician reputations, stock price drops, etc.

Excerpts:
"A 2014 analysis found that 4 years after 400 randomly selected trials finished, 30% of them hadn't published their results."

"The long-awaited changes to the HHS clinical-trial disclosure laws require, for the first time, that researchers report the design and results of all clinical trials and empowers the government to enforce penalties for those that do not comply. The NIH rules apply only to work done through agency grants, and include stricter reporting requirements for phase I trials. If institutions don't follow the rules, the NIH could withdraw their funding."